Also, Osmotica licenses rights to ophthalmic drug in Japan, China and the EMEA nations to Santen; Lilly and Chi-Med revise their partnership around colorectal cancer drug Elunate.

Nestle-backed Amazentis says clinical studies show its Timeline Cellular Nutrition delivers “significant” improvement in muscle strength after four months and delivers six times more urolithin A than pomegranate juice. Direct-to-consumer sales currently are available only in the US.

Swiss confections, food and nutritional products giant launches Nestlé Cerevita Instant Sour Porridge as affordable nutrition for consumers in Southeast Africa. With micronutrients often lacking in consumers’ diets there, it was developed in about one year by scientists at Nestlé's R&D center in Côte d'Ivoire.

The big biotech will pay $300m to acquire a 49.9% equity interest in the cancer immunotherapy startup with a buyout option. It is one of several immune checkpoints Gilead has secured access to this year.